In his role as Scientific Director at the Montreal Institute for Learning Algorithms, Yoshua Bengio leads significant advancements.
5.0 /10
In his role as Scientific Director at the Montreal Institute for Learning Algorithms, Yoshua Bengio leads significant advancements.
Recognized globally as a pivotal authority in the realm of artificial intelligence, Yoshua Bengio has made substantial contributions to deep learning techniques. His work earned him and colleagues Geoffrey Hinton and Yann LeCun the prestigious A.M. Turing Award in 2018, a title often deemed the Nobel Prize of Computing. He holds a full professorship at the Université de Montréal and is the founder and head of Mila, the Quebec AI Institute. In addition, he co-directs the CIFAR Learning in Machines & Brains program and serves as Scientific Director of IVADO.
Yoshua Bengio is a highly renownedartificial intelligence An expert acclaimed worldwide, Bengio's revolutionary research in deep learning has profoundly influenced the field. He shares the honor of the 2018 A.M. Turing Award, recognized as the ‘Nobel Prize of Computing’, received jointly with Geoffrey Hinton and Yann LeCun.
Beyond his role as the founder and Scientific Director of Mila – the Quebec AI Institute, Bengio is also a full professor at Université de Montréal. Additionally, he co-leads the CIFAR Learning in Machines & Brains initiative as a Senior Fellow while taking on the mantle of Scientific Director at IVADO.
In 2019, Bengio was awarded the prestigious Killam Prize. By 2022, he topped global citations among computer scientists. His accolades include being on the UN’s Scientific Advisory Board for Independent Advice on Breakthroughs in Science and Technology since 2023, as well as holding fellowships with the Royal Society of London and Canada, the title of Knight of the Legion of Honor in France, and being an Officer of the Order of Canada. He has also been recognized with the Canada CIFAR AI Chair. His concerns about AI's societal impact led him to be actively involved in drafting the Montreal Declaration for the Responsible Development of Artificial Intelligence.
2023
During his talk, Bengio discussed enhancing AI safety by utilizing increased computational power. His presentation, hosted by the Harvard School of Engineering and Applied Sciences, is titled 'Towards AI Safety that Improves with More Compute (rather than the other way around)'.Machine Learning Bengio opened his presentation by deliberating on the overarching concerns surrounding AI safety and methods to mitigate associated risks.
He emphasized, 'Most technology has dual purposes. It can be harnessed for beneficial uses, or it can be exploited with harmful intent. The more potent a technology is, the more we should be vigilant about this dual-use aspect.' Bengio warned that as processing capabilities of AI escalate, we might soon encounter forms of AI that could pose risks, necessitating democratic oversight. 'Those who wield these tools hold greater power, as intelligence equates to strength,' he stated, underlining the significance of this as we advance toward more sophisticated AI systems.
Throughout his career, Bengio has been a proponent of open-source software, highlighting its advantages in speeding up development and bolstering system security, particularly within cybersecurity. Open-source projects allow public access to their code, promoting collaborative examination, modification, and sharing.AI agent In conclusion, Bengio stressed the importance for governments to enhance their understanding of AI. He asserted that in order to regulate effectively and make democratic choices about AI's use, governments need to possess the knowledge and capabilities to comprehend, master, and utilize AI, even for self-defense.
Canada's Office of the Superintendent of Financial Institutions (OSFI) is looking into amending its capital and liquidity strategies concerning cryptocurrencies.
The proposed updates are intended to bolster institutions’ ability to manage cryptocurrency risks by categorizing digital assets into four distinct categories and specifying their capital treatment. These guidelines aim to be consistent with the recent banking standards set by the BCBS.
Latest news about Yoshua Bengio
Insilico Medicine has launched its first human trial for ISM5411, an oral PHD inhibitor aimed at treating inflammatory bowel disease (IBD). This drug, developed on Insilico’s proprietary AI platform, Pharma.AI, seeks to enhance long-term clinical outcomes by repairing the intestinal mucosa. The trial, which has commenced in Australia, aims to evaluate the drug's safety, tolerability, pharmacokinetics, and its interaction with food. This study reflects Insilico’s dedication to addressing critical clinical needs through AI acceleration in drug development.
Yoshua Bengio, the Scientific Director at the Montreal Institute for Learning Algorithms, contributes significantly to the field and is frequently featured in leading publications such as Metaverse Post.
